Cargando…
Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary
INTRODUCTION: In 1998, the first Japanese practice guidelines on osteoporosis was published. It has been updated several times, with the most recent being the full-scale 2011 edition and its abridged edition. The present guidelines provide information for the managements of primary osteoporosis in p...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517709/ https://www.ncbi.nlm.nih.gov/pubmed/23203733 http://dx.doi.org/10.1007/s11657-012-0109-9 |
_version_ | 1782252463992078336 |
---|---|
author | Orimo, Hajime Nakamura, Toshitaka Hosoi, Takayuki Iki, Masayuki Uenishi, Kazuhiro Endo, Naoto Ohta, Hiroaki Shiraki, Masataka Sugimoto, Toshitsugu Suzuki, Takao Soen, Satoshi Nishizawa, Yoshiki Hagino, Hiroshi Fukunaga, Masao Fujiwara, Saeko |
author_facet | Orimo, Hajime Nakamura, Toshitaka Hosoi, Takayuki Iki, Masayuki Uenishi, Kazuhiro Endo, Naoto Ohta, Hiroaki Shiraki, Masataka Sugimoto, Toshitsugu Suzuki, Takao Soen, Satoshi Nishizawa, Yoshiki Hagino, Hiroshi Fukunaga, Masao Fujiwara, Saeko |
author_sort | Orimo, Hajime |
collection | PubMed |
description | INTRODUCTION: In 1998, the first Japanese practice guidelines on osteoporosis was published. It has been updated several times, with the most recent being the full-scale 2011 edition and its abridged edition. The present guidelines provide information for the managements of primary osteoporosis in postmenopausal women and men over 50 years old, a summary of the evidence for the treatment of secondary osteoporosis, and a summary of the evidence for the prevention of osteoporosis in younger people. METHOD: The present Executive Summary is primarily based on the content of the 2011 Japanese abridged edition. One of the key changes is revision of the criteria for initiation of pharmacological treatment, along with an introduction of the fracture risk factors used in FRAX®. Key figures and tables were selected from the Japanese abridged edition and a reference list was added. RESULT AND CONCLUSIONS: The essential points of the Japanese practice guidelines on osteoporosis were translated into English for the first time. It is hoped that the content of the guidelines becomes known throughout the world. |
format | Online Article Text |
id | pubmed-3517709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-35177092012-12-11 Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary Orimo, Hajime Nakamura, Toshitaka Hosoi, Takayuki Iki, Masayuki Uenishi, Kazuhiro Endo, Naoto Ohta, Hiroaki Shiraki, Masataka Sugimoto, Toshitsugu Suzuki, Takao Soen, Satoshi Nishizawa, Yoshiki Hagino, Hiroshi Fukunaga, Masao Fujiwara, Saeko Arch Osteoporos Position Paper INTRODUCTION: In 1998, the first Japanese practice guidelines on osteoporosis was published. It has been updated several times, with the most recent being the full-scale 2011 edition and its abridged edition. The present guidelines provide information for the managements of primary osteoporosis in postmenopausal women and men over 50 years old, a summary of the evidence for the treatment of secondary osteoporosis, and a summary of the evidence for the prevention of osteoporosis in younger people. METHOD: The present Executive Summary is primarily based on the content of the 2011 Japanese abridged edition. One of the key changes is revision of the criteria for initiation of pharmacological treatment, along with an introduction of the fracture risk factors used in FRAX®. Key figures and tables were selected from the Japanese abridged edition and a reference list was added. RESULT AND CONCLUSIONS: The essential points of the Japanese practice guidelines on osteoporosis were translated into English for the first time. It is hoped that the content of the guidelines becomes known throughout the world. Springer-Verlag 2012-12-01 2012 /pmc/articles/PMC3517709/ /pubmed/23203733 http://dx.doi.org/10.1007/s11657-012-0109-9 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Position Paper Orimo, Hajime Nakamura, Toshitaka Hosoi, Takayuki Iki, Masayuki Uenishi, Kazuhiro Endo, Naoto Ohta, Hiroaki Shiraki, Masataka Sugimoto, Toshitsugu Suzuki, Takao Soen, Satoshi Nishizawa, Yoshiki Hagino, Hiroshi Fukunaga, Masao Fujiwara, Saeko Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary |
title | Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary |
title_full | Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary |
title_fullStr | Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary |
title_full_unstemmed | Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary |
title_short | Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary |
title_sort | japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary |
topic | Position Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517709/ https://www.ncbi.nlm.nih.gov/pubmed/23203733 http://dx.doi.org/10.1007/s11657-012-0109-9 |
work_keys_str_mv | AT orimohajime japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT nakamuratoshitaka japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT hosoitakayuki japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT ikimasayuki japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT uenishikazuhiro japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT endonaoto japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT ohtahiroaki japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT shirakimasataka japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT sugimototoshitsugu japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT suzukitakao japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT soensatoshi japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT nishizawayoshiki japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT haginohiroshi japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT fukunagamasao japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary AT fujiwarasaeko japanese2011guidelinesforpreventionandtreatmentofosteoporosisexecutivesummary |